• Voyager Technologies signed an MOU with Geisinger, expanding its VISTA space-research park into life sciences and biopharma.
• Parties will jointly pursue up to $1 million in external funding for microgravity-enabled clinical and biomedical research programs.
• Deal reserves research resources, tenant access, payload development support via Starlab, accelerating pathways from space-based research to patient care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607160900BIZWIRE_USPR_____20260716_BW546294) on July 16, 2026, and is solely responsible for the information contained therein.